scispace - formally typeset
M

Mohamed H Emara

Researcher at Kafrelsheikh University

Publications -  55
Citations -  452

Mohamed H Emara is an academic researcher from Kafrelsheikh University. The author has contributed to research in topics: Pegylated interferon & Ribavirin. The author has an hindex of 8, co-authored 55 publications receiving 345 citations. Previous affiliations of Mohamed H Emara include Zagazig University.

Papers
More filters
Journal ArticleDOI

Lactobacillus reuteri in management of Helicobacter pylori infection in dyspeptic patients: a double-blind placebo-controlled randomized clinical trial.

TL;DR: Test whether the addition of Lactobacillus reuteri to the standard triple therapy improves the eradication rates as well as the clinical and pathological aspects in H. pylori infection when compared with placebo-supplemented triple therapy found it to be effective.
Journal ArticleDOI

Cytokines genes polymorphisms in chronic hepatitis C: impact on susceptibility to infection and response to therapy.

TL;DR: In this paper, the association of IL28B rs12979860, TGF-β1-509, TNF-α 308, and IL-10-1082 polymorphisms with the susceptibility to hepatitis C virus genotype 4 infection and response to pegylated interferon-α and ribavirin therapy was evaluated.
Journal ArticleDOI

Emerging Role of Probiotics in the Management of Helicobacter Pylori Infection: Histopathologic Perspectives

TL;DR: There is growing evidence from preclinical and clinical studies that emphasizes the efficacy of probiotics in the management of Helicobacter pylori infection; it increased the eradication rate, improved patient clinical manifestations and lowered treatment associated side effects.
Journal ArticleDOI

Occult hepatitis B infection in egyptian chronic hepatitis C patients: prevalence, impact on pegylated interferon/ribavirin therapy

TL;DR: Detection of HBV DNA in HBsAg negative chronic HCV patients plays a non significant role in non-response of Egyptian patients to pegylated interferon/ribavirin therapy.